دورية
Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML
| العنوان: | Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML |
|---|---|
| المؤلفون: | Daver, Naval, Senapati, Jayastu, Maiti, Abhishek, Loghavi, Sanam, Kadia, Tapan M., DiNardo, Courtney D., Pemmaraju, Naveen, Jabbour, Elias, Montalban-Bravo, Guillermo, Tang, Guilin, Sasaki, Koji, Borthakur, Gautam, Yilmaz, Musa, Alvarez, Joie, Pierce, Sherry A., Nogueras González, Graciela M., Ning, Jing, Issa, Ghayas C., Andreeff, Michael, Abbas, Hussein A, Ravandi, Farhad, Garcia-Manero, Guillermo, Kantarjian, Hagop |
| المصدر: | Blood; November 2022, Vol. 140 Issue: Supplement 1 p141-144, 4p |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 00064971 15280020 |
|---|---|
| DOI: | 10.1182/blood-2022-170188 |